Your browser doesn't support javascript.
loading
Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA-IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study.
Ye, Jing-Ren; Chen, Pei-Hsing; Chuang, Jen-Hao; Lin, Mong-Wei; Tsai, Tung-Ming; Hsu, Hsao-Hsun; Chen, Jin-Shing.
Afiliación
  • Ye JR; Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen PH; Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
  • Chuang JH; Department of Surgical Oncology, National Taiwan University Cancer Center and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Lin MW; Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Tsai TM; Department of Surgical Oncology, National Taiwan University Cancer Center and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Hsu HH; Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen JS; Department of Surgical Oncology, National Taiwan University Cancer Center and National Taiwan University College of Medicine, Taipei, Taiwan.
Front Surg ; 9: 816018, 2022.
Article en En | MEDLINE | ID: mdl-35360423
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Surg Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Surg Año: 2022 Tipo del documento: Article País de afiliación: Taiwán